Secondary cross-clamping and blood cardioplegia for refractory ventricular fibrillation after aortic cross-clamp removal [2]
dc.authorscopusid | 6603931556 | |
dc.authorscopusid | 55666804700 | |
dc.authorscopusid | 7004486274 | |
dc.authorscopusid | 8408432900 | |
dc.authorscopusid | 6601993488 | |
dc.contributor.author | Turkoz A. | |
dc.contributor.author | Toprak H.I. | |
dc.contributor.author | Ersoy M.O. | |
dc.contributor.author | Gulcan O. | |
dc.contributor.author | Turkoz R. | |
dc.date.accessioned | 2024-08-04T19:59:31Z | |
dc.date.available | 2024-08-04T19:59:31Z | |
dc.date.issued | 2002 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [No abstract available] | en_US |
dc.identifier.endpage | 231 | en_US |
dc.identifier.issn | 0730-2347 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 12224735 | en_US |
dc.identifier.scopus | 2-s2.0-0036041678 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 230 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/90691 | |
dc.identifier.volume | 29 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Texas Heart Institute Journal | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | adrenalin | en_US |
dc.subject | dobutamine | en_US |
dc.subject | dopamine | en_US |
dc.subject | inotropic agent | en_US |
dc.subject | lidocaine | en_US |
dc.subject | aorta clamping | en_US |
dc.subject | aorta stenosis | en_US |
dc.subject | cardioplegia | en_US |
dc.subject | case report | en_US |
dc.subject | coronary artery bypass graft | en_US |
dc.subject | coronary artery disease | en_US |
dc.subject | defibrillation | en_US |
dc.subject | heart ventricle fibrillation | en_US |
dc.subject | human | en_US |
dc.subject | letter | en_US |
dc.subject | postoperative complication | en_US |
dc.subject | sinus rhythm | en_US |
dc.subject | Anti-Arrhythmia Agents | en_US |
dc.subject | Aortic Diseases | en_US |
dc.subject | Cardiac Surgical Procedures | en_US |
dc.subject | Cardioplegic Solutions | en_US |
dc.subject | Combined Modality Therapy | en_US |
dc.subject | Device Removal | en_US |
dc.subject | Humans | en_US |
dc.subject | Lidocaine | en_US |
dc.subject | Surgical Instruments | en_US |
dc.subject | Treatment Outcome | en_US |
dc.subject | Ventricular Fibrillation | en_US |
dc.title | Secondary cross-clamping and blood cardioplegia for refractory ventricular fibrillation after aortic cross-clamp removal [2] | en_US |
dc.type | Letter | en_US |